Your session is about to expire
← Back to Search
Speech Tasks for Understanding Brain Processing of Language
N/A
Waitlist Available
Led By Edward F Chang, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Participants with cognitive deficits that preclude reliable completion of study tasks.
Participants who lack capacity or decline to provide informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up between 10-30 minutes
Awards & highlights
No Placebo-Only Group
Summary
This trial is studying how the human brain extracts linguistic elements from speech. They will be recording neural activity from people speaking different languages to try and understand how the brain processes speech.
Who is the study for?
This trial is for individuals at UCSF with epilepsy or brain tumors who are undergoing surgery involving electrode implantation. They must be able to perform study tasks and have electrodes in at least two key brain areas. Those unable to consent, with significant cerebral lesions, or cognitive deficits that prevent task completion cannot participate.
What is being tested?
The study aims to understand how the brain processes speech across different languages by recording neural activity during surgery. It uses high-density electrodes and signal processing on patients speaking Mandarin, Spanish, and English to explore phonetic encoding in the temporal cortex.
What are the potential side effects?
Since this research involves non-invasive observation of neural activity during a surgical procedure already planned for other medical reasons, there are no additional side effects directly associated with the trial's interventions.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am able to understand and complete study tasks without difficulty.
Select...
I am unable or unwilling to give consent for this trial.
Select...
I have significant brain lesions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ between 10-30 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~between 10-30 minutes
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of Participants with Electrocorticography (ECoG) Signals for Neural Activity Identified During Intraoperative Procedure or Inpatient Hospitalization
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Electrocorticography (ECoG) recording during Speech TasksExperimental Treatment1 Intervention
Participants listened to 20-minute Speech Tasks while ECoG signals for neural activity was recorded during their intraoperative procedure or inpatient hospitalization at the University of California, San Francisco (UCSF).
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,586 Previous Clinical Trials
14,899,994 Total Patients Enrolled
2 Trials studying Speech
90 Patients Enrolled for Speech
University of California, BerkeleyOTHER
186 Previous Clinical Trials
640,696 Total Patients Enrolled
1 Trials studying Speech
60 Patients Enrolled for Speech
The University of Hong KongOTHER
1,194 Previous Clinical Trials
1,327,651 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have electrodes implanted in key areas and can participate in study tasks.I am having surgery at UCSF for epilepsy or a brain tumor, involving electrode implantation.I am able to understand and complete study tasks without difficulty.I am unable or unwilling to give consent for this trial.I have significant brain lesions.
Research Study Groups:
This trial has the following groups:- Group 1: Electrocorticography (ECoG) recording during Speech Tasks
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger